Amneal Pharmaceuticals, Inc. AMRX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported deferred tax assets and other non-current assets of $54.88M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets increased by 20.8% year-over-year, from $45.42M to $54.88M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s deferred tax assets and other non-current assets has grown at a 20.9% compound annual growth rate (CAGR), from $22.34M to $57.81M.